Remdesivir Trial Data Leak Shows No Benefits in COVID-19 Patients

Results from a Chinese trial of Gilead’s antiviral remdesivir show no benefit in COVID-19 patients, according to data accidentally posted on the World Health Organization’s (WHO) website.
Source: Devices & Diagnostics Letter